Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Lifeng Li

2PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|May 15, 2026
A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma.

|Jan 06, 2025
Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3-year survival update and multi-omics analysis.

Jie Dai, Tianxiao Xu, Lifeng Li

Pageof 1

Frequent Collaborators

2 joint publications

Lu Si

1 joint publications

Jing Lin

1 joint publications

Yu Chen

1 joint publications

Yan Kong

1 joint publications

Xinan Sheng

1 joint publications

Li Zhou

Frequent Collaborators

2 joint publications

Lu Si

1 joint publications

Jing Lin

1 joint publications

Yu Chen

1 joint publications

Yan Kong